2016 ACR/ARHP Annual Meeting

November 11-16, 2016. Washington, DC.

View by Number View by Title View Sessions

View by Date

Abstract Number: 27

A Rheumatologist’s Assessment of Therapy Responses (Rxresp) and Rheumatoid Factor Status (neg/pos) in 1995 Predicted Mortality through 2015 in a Community-Based Cohort of Incident Rheumatoid Arthritis Cases and Matched Control Subjects
Abstract Number: 28

Baseline Serum Inflammatory Biomarkers at Cohort Entry in 1974 Predicted Cardiovascular Disease (CVD) Mortality from 1995 through 2015 in a Prospective, Community-Based Study of Incident Rheumatoid Arthritis (RA) Patients and Matched Non-RA (CN) Subjects
Abstract Number: 29

Risk of Vascular Mortality in Seniors with New-Onset Rheumatoid Arthritis
Abstract Number: 30

Impact of Interstitial Lung Disease on Mortality of Patients with Rheumatoid Arthritis
Abstract Number: 31

Patients with Either Rheumatoid Arthritis (RA) or Axial Spondyloarthritis (axSpA) Self-Reported Flares in 24% of Assessments: An Observational Study of 86 Patients Assessed Weekly over 3 Months (ie, 1,100 assessments)
Abstract Number: 32

Comparison of Effects of Leukocyte-RICH and Leukocyte-Poor Platelet-RICH Plasma on PAIN and Functionality in Patients with Lateral Epicondylitis
Abstract Number: 33

Prevalence of Growth Hormone Deficiency in Fibromyalgia Patients
Abstract Number: 34

Differential Analgesic Pharmacological Effects on Brain Connectivity in Fibromyalgia (FM)
Abstract Number: 35

WITHDRAWN
Abstract Number: 36

Dysautonomia and Osteoporosis in 2300 Ehlers-Danlos Hypermobile Patients, As Defined By the Brighton Criteria
Abstract Number: 37

Association Between Fibromyalgia and Bone Mineral Density: A Systematic Review and Meta-Analysis
Abstract Number: 38

How Does Thiol/Disulphide Homeostasis Change in Fibromyalgia Patients?
Abstract Number: 39

Effects of Pregabalin (Lyrica®) on Cerebrospinal Fluid Substance P in Human Subjects with Fibromyalgia Syndrome
Abstract Number: 40

Lateral Epicondylitis Treatment: Comparison of Bandage, Laser Therapy and Extra-Corporeal Shock Wave Therapy
Abstract Number: 41

Human Papilloma Virus Vaccination, Fibromyalgia and Dysautonomia

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].